Teradyne makes machines that test other machines. When a chip company finishes designing a new semiconductor, it cannot ship that chip to customers until it knows the chip works correctly. Teradyne builds the automated test equipment that does that checking, at high speed, for millions of chips at a time. The company also sells collaborative robot arms (called cobots) and autonomous mobile robots that help factories and warehouses move things around without human labor. Nearly every dollar Teradyne earns comes from selling a discrete piece of equipment to a customer, one transaction at a time. That makes the business sensitive to the ups and downs of the technology industry. The diagram below traces where the money goes.
How Teradyne Makes Money
flowchart LR
A["Customer Demand:
AI, Memory, Defense"] --> B["Semiconductor Test
Product Test Sales"]
C["Robotics Sales:
Cobots, AMRs"] --> D["Three Revenue Streams
3.2B total"]
B --> D
D --> E["Gross Margin
58.2%"]
E --> F["Operating Profit
20.4% margin"]
F --> G["R&D & M&A Investment
157M MLTP, 127M Quantifi"]
G --> H["New Products & Platforms
UltraFlexplus, PIC solutions"]
H --> B
H --> C
F --> I["Cash Returns
Dividends & Buybacks"]
A --> C
Five years of financial data tell a story of a boom, a correction, and a recovery. Revenue peaked at $3.7 billion in 2021, then fell for two straight years, dropping to $2.7 billion in 2023. That slide happened because chipmakers had over-ordered test equipment during the pandemic technology surge and then pulled back sharply. Revenue started recovering in 2024 and reached $3.2 billion in 2025, matching the 2022 level. The recovery was not broad. It was driven almost entirely by one force: demand for chips that power artificial intelligence systems.
Teradyne Annual Revenue (2021 to 2025)
Revenue in billions of dollars. The 2021 peak was followed by two years of decline before AI-driven demand began lifting results in 2024.
The Semiconductor Test segment brought in $2.52 billion in 2025, up from $2.12 billion the year before. That $400 million jump came mostly from testing chips used in AI computing and networking. By the second half of 2025, AI-related customer demand was driving the majority of Semiconductor Test revenue. The Product Test segment, which covers defense, aerospace, wireless, and photonic chip testing, added $358 million. The Robotics segment, which sells cobot arms under the Universal Robots brand and mobile robots under the Mobile Industrial Robots brand, fell to $308 million from $365 million in 2024, a drop of 15.5%.
79%
Share of 2025 revenue from Semiconductor Test alone
Gross margin, the share of each dollar of revenue left after the cost of making the product, has been remarkably steady despite the revenue swings. It stayed between 57% and 60% every year from 2021 through 2025. That consistency suggests Teradyne has real pricing power in its test equipment business. Operating cash flow tells a similar story. Even in the down years of 2022 and 2023, the company generated $600 million in cash from operations each year. In 2025 it produced $674 million. The company carries more cash than debt: net debt was negative $1.1 billion in 2021, meaning Teradyne had more cash than it owed, and while that cushion has narrowed to negative $100 million by 2025, the company still has no net debt burden.
What is customer concentration risk?
When a company gets a large chunk of its revenue from just a few customers, it is exposed to concentration risk. If one of those big customers stops ordering, the company's revenue can drop fast. The more concentrated the customer base, the bigger the potential impact of losing any single relationship.
The customer concentration picture has been getting more extreme, not less. In 2023, the five largest customers accounted for 32% of revenue. By 2024 that was 36%. In 2025 it reached 44%. One direct customer alone accounted for 19% of all consolidated revenue in 2025. Two other customers each specified more than 10% of revenue. This is not a distant theoretical risk. It is a structural feature of the business right now, and it is growing more concentrated over time.
44%
Share of 2025 revenue from just five customers
Export controls add another layer of risk that is difficult to manage. The U.S. government restricts which companies and countries Teradyne can sell to, particularly certain Chinese semiconductor manufacturers. The company has acknowledged that these restrictions limit its ability to compete, especially in markets where some rivals face no equivalent rules. China represented 14% of revenue in 2025. Taiwan jumped to 36% from 21% the year before, partly reflecting where AI chip testing demand is concentrated. Any tightening of export rules or escalation of trade tensions with China could shift those numbers in ways that are hard to predict.
2025
milestone
Teradyne pivots toward AI and photonics
In 2025, Teradyne acquired Quantifi Photonics for $127.2 million to build out testing capabilities for photonic integrated circuits, the technology used in high-speed data connections inside AI data centers. It also acquired Infineon's automated test equipment team for $18.3 million to deepen a key customer relationship. Then in January 2026, it announced a joint venture with MultiLane, investing $157 million for 75% ownership, to develop test solutions for the high-speed connections that AI data centers depend on. These moves mark a deliberate effort to embed Teradyne deeper into the AI infrastructure supply chain.
The Robotics segment is the one part of the business moving in the wrong direction. Revenue fell $56.5 million in 2025 and the segment lost $99.4 million before taxes, worse than the $77.6 million loss in 2024. Teradyne cut roughly 400 Robotics employees in 2025, recording $24.3 million in severance charges related to that restructuring. The company expects sequential revenue growth to continue after three consecutive quarters of improvement through the end of 2025, but Robotics remains unprofitable and dependent on a turnaround that has not arrived yet.
What is a cobot?
A cobot, short for collaborative robot, is a robotic arm designed to work safely alongside people on a factory floor, rather than being caged off in a separate area like traditional industrial robots. Cobots are generally lighter, cheaper, and easier to program than traditional robots. Teradyne's Universal Robots brand claims to have introduced the first commercially viable cobot.
The supply chain for Teradyne's test equipment relies heavily on contract manufacturers in Malaysia and Thailand, particularly for the FLEX and Magnum product lines. If those manufacturers face disruptions, Teradyne could lose orders and face serious delays finding replacements, especially during periods when AI-related demand is surging and speed of delivery matters most. The company also acknowledged it has experienced component delivery delays that have already affected product manufacturing and timing.
Teradyne returned $778.4 million to shareholders in 2025 through share repurchases and dividends, even as it spent $144.4 million on acquisitions. That required borrowing $250 million from its revolving credit facility during the year.
$778M
Cash returned to shareholders in 2025
$674M
Operating cash generated in 2025
Teradyne returned more cash than it generated from operations in 2025, funding the gap with debt. The credit facility expires in December 2026.
The Bet
Teradyne's recovery depends on AI chip demand remaining strong enough, and concentrated enough in the specific chips that require Teradyne's test platforms, to keep Semiconductor Test growing while the Robotics segment finds its footing. If AI hardware spending slows, shifts to chips that need less testing, or moves to test equipment from competitors like Advantest, the revenue recovery stalls and the Robotics losses become harder to absorb. The company has bet its capital, its acquisitions, and its engineering investment on AI infrastructure being a durable, multi-year growth driver rather than a cyclical wave that recedes as quickly as it arrived.
Open question
Teradyne's test equipment business is generating steady cash, gross margins have barely moved in five years, and the company is spending aggressively to embed itself in AI data center infrastructure through Quantifi and the MultiLane joint venture. But 79% of revenue comes from one segment, one customer accounts for nearly a fifth of all sales, the Robotics business is losing money, and the credit facility that helped fund $778 million in shareholder returns expires in December 2026. Is the AI testing wave durable enough to carry the company through a Robotics turnaround and justify deepening concentration in a single technology cycle, or is this a familiar boom-bust pattern dressed in new language?
Compiled · 10-K · FY2025
Customer Concentration
Teradyne depends heavily on a small number of large customers. In 2025, the five biggest customers made up 44% of total revenue, with two customers each accounting for more than 10% of sales. If any of these major customers stops buying or significantly reduces orders, revenue could drop sharply and hurt the company's financial health.
Export Controls and Trade Restrictions
The U.S. government restricts which countries and companies Teradyne can sell to, especially Chinese semiconductor manufacturers on the Entity List. These restrictions have already hurt sales to certain customers and could worsen if new export control rules are added. The company cannot guarantee it will get licenses to bypass these restrictions.
Supply Chain Dependency
Teradyne relies on specific contract manufacturers in Malaysia, Thailand and other countries to make key products like the FLEX and Magnum lines. If these manufacturers cannot deliver products on time or go out of business, Teradyne could lose customer orders and face significant delays in finding replacements, especially during periods of rapid growth.
China Business and Geopolitical Risk
Teradyne faces uncertainty from China's unpredictable legal system, currency controls, and potential changes in laws and regulations. Ongoing U.S.-China tensions, retaliatory tariffs, and blocking legislation from China create risk that the company's ability to do business there could be restricted or its costs could increase significantly.
Integration of Recent Acquisitions
Teradyne acquired AET and Quantifi in 2025 and owns a stake in Technoprobe. The company may not successfully integrate these businesses, realize expected cost savings, or achieve the revenue and profit levels needed to justify these acquisitions. Failed integration could result in write-offs of goodwill and harm operating results.
10-K Item 1A · Risk Factors
